A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
Status:
Withdrawn
Trial end date:
2017-06-22
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to demonstrate that tolvaptan effectively and safely increases
and maintains serum sodium concentrations in children and adolescent subjects with euvolemic
or hypervolemic hyponatremia.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.